186 related articles for article (PubMed ID: 30697073)
1. Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer.
Wang P; Yue W; Li W; Luo Y; Li Z; Shao Y; He Z
Cancer Manag Res; 2019; 11():813-819. PubMed ID: 30697073
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer.
Liu J; Shi Z; Bai Y; Liu L; Cheng K
Cancer Manag Res; 2019; 11():4471-4480. PubMed ID: 31191009
[No Abstract] [Full Text] [Related]
3. Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.
Pang J; Wang S; Liao L; Liu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):958-965. PubMed ID: 34707005
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
5. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients.
Sun Y; Li W; Li AJ; Su H; Yue J; Yu J
Cancer Manag Res; 2019; 11():3153-3162. PubMed ID: 31114357
[No Abstract] [Full Text] [Related]
6. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy.
Li Y; Shao Y; Bai L; Zhou X
Cancer Manag Res; 2018; 10():3841-3847. PubMed ID: 30288115
[TBL] [Abstract][Full Text] [Related]
7. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
9. High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab.
Jiang L; Fang J; Ding J
Cancer Manag Res; 2020; 12():475-484. PubMed ID: 32021460
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
11. The Change of Systemic Immune-Inflammation Index Independently Predicts Survival of Colorectal Cancer Patients after Curative Resection.
Chen Q; Wu H; Guo X; Gu K; Wang W; Chen X; Ji S; Yang H; Zhu J
Mediators Inflamm; 2020; 2020():4105809. PubMed ID: 33293896
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
[TBL] [Abstract][Full Text] [Related]
13. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
14. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer.
Ren K; Yin Y; He F; Shao Y; Wang S
Cancer Manag Res; 2018; 10():4891-4898. PubMed ID: 30425580
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer.
Wang Q; Zhu D
J Gastrointest Oncol; 2019 Oct; 10(5):965-978. PubMed ID: 31602335
[TBL] [Abstract][Full Text] [Related]
18. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus.
Gu Y; Fu Y; Pan X; Zhou Y; Ji C; Zhao T; Miao H; Lv H; Da J; Ge J; Wang L; Qu L; Ge S; Guo H; Zhou W
Front Oncol; 2023; 13():1117595. PubMed ID: 36776325
[TBL] [Abstract][Full Text] [Related]
20. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]